Tubedown-1, a novel acetyltransferase associated with blood vessel development

Developmental Dynamics

Volumn 218, Issue 2, 2000, Pages 300-315

  Gendron, Robert L ^a,b   Adams, Lisa C ^a   Paradis, Hélène ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Acetyltransferase; Blood vessels; Development

Indexed keywords

ACYLTRANSFERASE; BASIC FIBROBLAST GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CAPILLARY; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENDOTHELIUM CELL; GENE EXPRESSION; GENE ISOLATION; HEMATOPOIESIS; LEUKEMIA CELL; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; YOLK SAC;

ACETYLTRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; BLOOD VESSELS; CELLS, CULTURED; CHICKENS; DNA, COMPLEMENTARY; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; MOLECULAR SEQUENCE DATA;

EID: 0034076940     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K     Document Type: Article

References (49)

1. Almouzni G, Khochbin S, Dimitrov S, Wolffe AP. 1994. Histone acetylation influences both gene expression and development of Xenopus laevis. Dev Biol 165:654-669.
2. Baima S, Nobili F, Sessa G, Lucchetti S, Ruberti I, Morelli G. 1995. The expression of the Athb-8 homeobox gene is restricted to provascular cells in arabidopsis thaliana. Development 121:4171-4182.
3. Beck L, Jr, D'Amore PA. 1997. Vascular development: cellular and molecular regulation. FASEB J 11:365-373.
4. Bode J, Gomez-Lira MM, Schroter H. 1983. Nucleosomal particles open as the histone core becomes hyperacetylated. Eur J Biochem 130:437-445.
5. Brownell JE, Allis CD. 1996. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6:176-184.
6. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-732.
7. Conget PA, Minguell JJ. 1999. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67-73.
8. Coulson M, Robert S, Eyre HJ, Saint R. 1998. The identification and localization of a human gene with sequence similarity to Polycomblike of Drosophila melanogaster. Genomics 48:381-383.
9. Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. 1995. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203:80-92.
10. Feinberg AP, Vogelstein B. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
11. Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH. 1998. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4(3):336-340.
12. Flamme I, Frolich T, Risau W. 1997. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173:206-210.
13. Futamura M, Monden Y, Okabe T, Fujita-Yoshigaki J, Yokoyama S, Nishimura S. 1995. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. Oncogene 10:1119-1123.
14. Gendron RL, Tsai FY, Paradis H, Arceci RJ. 1996. Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev Biol 177:332-346.
15. Georgieva EI, Sendra R. 1999. Mobility of acetylated histones in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem 269(2):399-402.
16. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 78:1385-1394.
17. Gory-Faure S, Prandini MH, Pointu H, Roullot V, Pignot-Paintrand I, Vernet M, Huber P. 1999. Role of vascular endothelial-cadherin in vascular morphogenesis. Development 126:2093-2102.
18. Gu W, Roeder RG. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
19. Herrera JE, Bergel M, Yang XJ, Nakatani Y, Bustin M. 1997. The histone acetyltransferase activity of human GCN5 and PCAF is stabilized by coenzymes. J Biol Chem 272:27253-27258.
20. Hilfiker A, Hilfiker-Kleiner D, Pannuti A, Lucchesi JC. 1997. mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J 16:2054-2060.
21. Islam A, Glomski C, Henderson ES. 1992. Endothelial cells and hematopoiesis: a light microscopic study of fetal, normal, and pathologic human bone marrow in plastic-embedded sections. Anat Rec 233:440-452.
22. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM, Yokoyama KK. 1998. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393:284-289.
23. Kozak M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
24. Kozak M. 1995. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc Natl Acad Sci USA 92: 2662-2666.
25. Lin Y, Fletcher CM, Zhou J, Allis CD, Wagner G. 1999. Solution structure of the catalytic domain of GCN5 histone acetyltransferase bound to coenzyme A. Nature 400(6739):86-89.
26. Lonie A, D'Andrea R, Paro R, Saint R. 1994. Molecular characterisation of the Polycomblike gene of Drosophila melanogaster, a transacting negative regulator of homeotic gene expression. Development 120:2629-2636.
27. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
28. Metcalf D, Hilton DJ, Nicola NA. 1988. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells. Leukemia 2:216-221.
29. Miyashita T, Yamamoto H, Nishimune Y, Nozaki M, Morita T, Matsushiro A. 1994. Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A. FEBS Lett 353:225-229.
30. Moss DW, Thomas DM. 1970. Modification of the electrophoretic mobility of serum alkaline phosphatase by acetylation. Clin Chim Acta 30:835-838.
31. Mullen JR, Kayne PS, Moerschell RP, Tsunasawa S, Gribskov M, Colavito-Shepanski M, Grunstein M, Sherman F, Sternglanz R. 1989. Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast. EMBO J 8:2067-2075.
32. Ng WA, Doetschman T, Robbins J, Lessard JL. 1997. Muscle isoactin expression during in vitro differentiation of murine embryonic stem cells. Pediatr Res 41:285-292.
33. Ogryzko W, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
34. Paradis H, Arceci RJ, Adams LC, Gendron RL. 1998. Differentiation responses of embryonic endothelium to leukemia inhibitory factor. Exp Cell Res 240:7-15.
35. Park EC, Szostak JW. 1992. ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J 11:2087-2093.
36. Rafii S, Mohle R, Shapiro F, Frey BM, Moore MA. 1997. Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma 27: 375-386.
37. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
38. Risau W. 1998. Development and differentiation of endothelium. Kidney Int Suppl 67:83-6.
39. Risau W, Flamme I. 1995. Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91.
40. Robb L, Elefanty AG. 1998. The hemangioblast - an elusive cell captured in culture. Bioessays 20:611-614.
41. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning, a laboratory manual, 2nd Edition. New York: Cold Spring Harbor Laboratory Press, p 6.3-7.79.
42. Sartorelli V, Huang J, Hamamori Y, Kedes L. 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 17:1010-1026.
43. Sawtell NM, Lessard JL. 1989. Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the alpha-vascular but not the gamma-enteric isoform in differentiating striated myocytes. J Cell Biol 109:2929-2937.
44. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
45. Utley RT, Ikeda K, Grant PA, Cote J, Steger DJ, Eberharter A, John S, Workman JL. 1998. Transcriptional activators direct histone acetyltransferase complexes to nucleosomes. Nature 394:498-502.
46. Wheater PR, Burkitt HG, Daniels VG. 1979. Functional histology. Edinburgh: Churchill Livingston. 278 p.
47. Williams FE, Varanasi U, Trumbly RJ. 1991. The CYC8 and TUP1 proteins involved in glucose repression in Saccharomyces cerevisiae are associated in a protein complex. Mol Cell Biol 11:3307-3316.
48. Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Hamid AA, Yura Y, Mori T. 1997. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol Endocrinol 11(6):371-378.
49. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.